Abstract
The adult stage of Nippostrongylus brasiliensis, a strongyloid parasite of the gastrointestinal tract of rats, released a product during in vitro culture which functionally inhibited platelet-activating factor (PAF), measured by its ability to mediate platelet aggregation. The extent of inhibition was proportional to the concentration of excretory/secretory (ES) products and the duration of preincubation with PAF prior to the assay of biological activity. The inhibitory activity was heat labile and was specific for PAF, as incubation of ES products with thrombin showed no diminution of platelet aggregation. Experiments using radiolabelled preparations of PAF demonstrated that the acetyl group esterified at the sn-2 position of the glycerol backbone was liberated on incubation with ES products, indicative of an acetylhydrolase activity. This activity was susceptible to inhibition by DFP, partial inhibition by eserine, but was resistant to PMSF and TPCK at concentrations which inhibit serine proteases.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benveniste J., Tencé M., Varenne P., Bidault J., Boullet C., Polonsky J. Semi-synthèse et structure proposée du facteur activant les plaquettes (P.A.F.): PAF-acether, un alkyl ether analogue de la lysophosphatidylcholine. C R Seances Acad Sci D. 1979 Nov 26;289(14):1037–1040. [PubMed] [Google Scholar]
- Blank M. L., Hall M. N., Cress E. A., Snyder F. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun. 1983 Jun 15;113(2):666–671. doi: 10.1016/0006-291x(83)91778-3. [DOI] [PubMed] [Google Scholar]
- Blank M. L., Lee T., Fitzgerald V., Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem. 1981 Jan 10;256(1):175–178. [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
- Bushfield M., McNicol A., MacIntyre D. E. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. Biochem J. 1985 Nov 15;232(1):267–271. doi: 10.1042/bj2320267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bushfield M., McNicol A., MacIntyre D. E. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. Biochem J. 1985 Nov 15;232(1):267–271. doi: 10.1042/bj2320267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chatonnet A., Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J. 1989 Jun 15;260(3):625–634. doi: 10.1042/bj2600625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Demopoulos C. A., Pinckard R. N., Hanahan D. J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem. 1979 Oct 10;254(19):9355–9358. [PubMed] [Google Scholar]
- Dubois C., Bissonnette E., Rola-Pleszczynski M. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors. J Immunol. 1989 Aug 1;143(3):964–970. [PubMed] [Google Scholar]
- ELLMAN G. L., COURTNEY K. D., ANDRES V., Jr, FEATHER-STONE R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961 Jul;7:88–95. doi: 10.1016/0006-2952(61)90145-9. [DOI] [PubMed] [Google Scholar]
- Farr R. S., Wardlow M. L., Cox C. P., Meng K. E., Greene D. E. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Fed Proc. 1983 Nov;42(14):3120–3122. [PubMed] [Google Scholar]
- Hanahan D. J., Demopoulos C. A., Liehr J., Pinckard R. N. Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem. 1980 Jun 25;255(12):5514–5516. [PubMed] [Google Scholar]
- Ho Y. S., Lee W. M., Snyderman R. Chemoattractant-induced activation of c-fos gene expression in human monocytes. J Exp Med. 1987 Jun 1;165(6):1524–1538. doi: 10.1084/jem.165.6.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Houslay M. D., Bojanic D., Wilson A. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J. 1986 Mar 15;234(3):737–740. doi: 10.1042/bj2340737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hwang S. B., Lam M. H., Pong S. S. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. J Biol Chem. 1986 Jan 15;261(2):532–537. [PubMed] [Google Scholar]
- Jenkins D. C., Phillipson R. F. The kinetics of repeated low-level infections of Nippostrongylus brasiliensis in the laboratory rat. Parasitology. 1971 Jun;62(3):457–465. doi: 10.1017/s003118200007760x. [DOI] [PubMed] [Google Scholar]
- Kroegel C., Yukawa T., Dent G., Venge P., Chung K. F., Barnes P. J. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol. 1989 May 15;142(10):3518–3526. [PubMed] [Google Scholar]
- Lapetina E. G., Silió J., Ruggiero M. Thrombin induces serotonin secretion and aggregation independently of inositol phospholipids hydrolysis and protein phosphorylation in human platelets permeabilized with saponin. J Biol Chem. 1985 Jun 10;260(11):7078–7083. [PubMed] [Google Scholar]
- Leid R. W., Grant R. F., Suquet C. M. Inhibition of equine neutrophil chemotaxis and chemokinesis by a Taenia taeniaeformis proteinase inhibitor, taeniaestatin. Parasite Immunol. 1987 Mar;9(2):195–204. doi: 10.1111/j.1365-3024.1987.tb00500.x. [DOI] [PubMed] [Google Scholar]
- Lewis G. P. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull. 1983 Jul;39(3):243–248. doi: 10.1093/oxfordjournals.bmb.a071827. [DOI] [PubMed] [Google Scholar]
- Liu L. X., Serhan C. N., Weller P. F. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J Exp Med. 1990 Sep 1;172(3):993–996. doi: 10.1084/jem.172.3.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Macpherson J. L., Kemp A., Rogers M., Mallet A. I., Toia R. F., Spur B., Earl J. W., Chesterman C. N., Krilis S. A. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. Clin Exp Immunol. 1989 Sep;77(3):391–396. [PMC free article] [PubMed] [Google Scholar]
- Mazingue C., Camus D., Dessaint J. P., Capron M., Capron A. In vitro and in vivo inhibition of mast cell degranulation by a factor from Schistosoma mansoni. Int Arch Allergy Appl Immunol. 1980;63(2):178–189. doi: 10.1159/000232624. [DOI] [PubMed] [Google Scholar]
- Michel L., Denizot Y., Thomas Y., Jean-Louis F., Pitton C., Benveniste J., Dubertret L. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. J Immunol. 1988 Aug 1;141(3):948–953. [PubMed] [Google Scholar]
- Miwa M., Hill C., Kumar R., Sugatani J., Olson M. S., Hanahan D. J. Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver. J Biol Chem. 1987 Jan 15;262(2):527–530. [PubMed] [Google Scholar]
- Moqbel R. Helminth-induced intestinal inflammation. Trans R Soc Trop Med Hyg. 1986;80(5):719–727. doi: 10.1016/0035-9203(86)90370-6. [DOI] [PubMed] [Google Scholar]
- Moqbel R., Walsh G. M., Nagakura T., MacDonald A. J., Wardlaw A. J., Iikura Y., Kay A. B. The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils. Immunology. 1990 Jun;70(2):251–257. [PMC free article] [PubMed] [Google Scholar]
- Ogilvie B. M., Jones V. E. Parasitological review. Nippostrongylus brasiliensis: a review of immunity and host-parasite relationship in the rat. Exp Parasitol. 1971 Feb;29(1):138–177. doi: 10.1016/0014-4894(71)90021-x. [DOI] [PubMed] [Google Scholar]
- Rosenberry T. L. Acetylcholinesterase. Adv Enzymol Relat Areas Mol Biol. 1975;43:103–218. doi: 10.1002/9780470122884.ch3. [DOI] [PubMed] [Google Scholar]
- Schumacher M., Camp S., Maulet Y., Newton M., MacPhee-Quigley K., Taylor S. S., Friedmann T., Taylor P. Primary structure of acetylcholinesterase: implications for regulation and function. Fed Proc. 1986 Dec;45(13):2976–2981. [PubMed] [Google Scholar]
- Suquet C., Green-Edwards C., Leid R. W. Isolation and partial characterization of a Taenia taeniaeformis metacestode proteinase inhibitor. Int J Parasitol. 1984 Apr;14(2):165–172. doi: 10.1016/0020-7519(84)90044-4. [DOI] [PubMed] [Google Scholar]
- Toutant J. P. Insect acetylcholinesterase: catalytic properties, tissue distribution and molecular forms. Prog Neurobiol. 1989;32(5):423–446. doi: 10.1016/0301-0082(89)90031-2. [DOI] [PubMed] [Google Scholar]
- Vigo C. Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. J Biol Chem. 1985 Mar 25;260(6):3418–3422. [PubMed] [Google Scholar]
- Watson S. P., Hambleton S. Phosphorylation-dependent and -independent pathways of platelet aggregation. Biochem J. 1989 Mar 1;258(2):479–485. doi: 10.1042/bj2580479. [DOI] [PMC free article] [PubMed] [Google Scholar]